CT
OGN icon

Clearstead Trust’s Organon & Co OGN Stock Holding History

Clearstead Trust’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03K Buy
76
+53
+230% +$634 ﹤0.01% 934
2026
Q1 		$138 Sell
23
-62
-73% -$467 ﹤0.01% 981
2025
Q4 		$610 Sell
85
-43
-34% -$340 ﹤0.01% 974
2025
Q3 		$1.37K Sell
128
-633
-83% -$6.21K ﹤0.01% 1122
2025
Q2 		$7.37K Buy
761
+553
+266% +$5.7K ﹤0.01% 661
2025
Q1 		$3.1K Buy
208
+170
+447% +$2.61K ﹤0.01% 704
2024
Q4 		$567 Buy
38
+23
+153% +$375 ﹤0.01% 428
2024
Q3 		$287 Hold
15
– – ﹤0.01% 412
2024
Q2 		$311 Hold
15
– – ﹤0.01% 430
2024
Q1 		$282 Sell
15
-17
-53% -$292 ﹤0.01% 424
2023
Q4 		$462 Sell
32
-103
-76% -$1.4K ﹤0.01% 408
2023
Q3 		$2.34K Hold
135
– – ﹤0.01% 409
2023
Q2 		$2.81K Sell
135
-14
-9% -$304 ﹤0.01% 351
2023
Q1 		$3.5K Sell
149
-273
-65% -$7.33K ﹤0.01% 330
2022
Q4 		$12K Sell
422
-268
-39% -$6.85K ﹤0.01% 302
2022
Q3 		$16K Buy
+690
New +$20.8K 0.01% 268

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Clearstead Trust's OGN Position: Q2 2026 in Review

Clearstead Trust increased its Organon & Co (OGN) stake by 230% in Q2 2026, buying an estimated $634 and bringing the position to 76 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #934.

Clearstead Trust first reported a position in OGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $16K in Q3 2022. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Clearstead Trust held 76 shares of Organon & Co worth $1.03K as of Q2 2026.
  • Clearstead Trust bought 53 Organon & Co shares in Q2 2026, an estimated $634.
  • Organon & Co made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #934 holding.
  • Clearstead Trust first reported a position in Organon & Co in Q3 2022 and has held it in 16 quarters since.
  • Clearstead Trust's Organon & Co position peaked at $16K in Q3 2022.
  • 635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.